Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1 ...

Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed.

Solventum is selling its purification and filtration business to Thermo Fisher for $4.1 billion, using most of the proceeds to reduce debt. The deal is part of Solventum’s transformation ...

Solventum Corp. (NYSE: SOLV), which spun off from 3M Co. (NYSE: MMM) almost a year ago, has sold its purification and filtration business to Thermo Fisher Scientific in a deal worth $4.1 billion.

The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers to explore a sale of its purification and filtration unit.

MAPLEWOOD, Minn. (AP) — MAPLEWOOD, Minn. (AP) — Solventum Corp. (SOLV) on Thursday reported fourth-quarter net income of $30 million. The Maplewood, Minnesota-based company said it had net ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per share was 7.8% above analysts ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 ...